TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
SCLX

Scilex Holding Company

Healthcare · Drug Manufacturers - General

4.90$ -1.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Ratios

Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.

Tick rows to compare them in a chart (up to 4)

Ratios SCLX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
Valuation
2.7 3.6 2.7 2.8 1.4 1.2 0.7 0.6 2.1 1.8 0.8 1.7
5.4 6.2 5.0 4.7 1.6 1.7 1.4 1.4 3.5 2.3 3.4 4.3
– – – 12.4 7.1 3.5 2.5 1.3 3.6 13.8 – –
-28.5% -12.6% -3.3% 8.1% 14.0% 28.8% 40.7% 79.7% 28.1% 7.3% -21.3% -32.5%
Margins
65.3% 64.2% 63.9% 66.2% 68.2% 70.5% 71.9% 70.4% 68.6% 65.0% 59.7% 46.5%
-236.4% -225.6% -211.4% -181.5% -137.5% -151.8% -186.0% -224.3% -652.4% -900.4% -817.1% -903.5%
-245.2% -244.6% -229.5% -233.9% -159.1% -128.7% -146.9% -278.0% -931.2% -1,330.4% -1,239.4% -1,414.6%
-76.8% -45.2% -8.8% 22.6% 19.4% 33.1% 30.3% 45.8% 59.0% 12.8% -18.1% -55.2%
Returns
-137.6% -112.9% -118.3% -113.7% -87.4% -78.3% -94.3% -146.8% -136.2% -110.3% -142.9% -176.3%
Balance Sheet & Debt
121 122 108 98 14 33 34 37 54 18 85 82
-202.0% -170.7% -208.0% -205.4% -210.4% -207.2% -267.8% -297.3% -64.1% -56.9% -84.9% -121.6%
Per Share
-27.74 -29.63 -29.61 -34.62 -23.32 -10.47 -10.77 -17.77 -54.30 -57.23 -60.90 -64.87
11.32 12.11 12.90 14.80 14.65 8.14 7.33 6.39 5.83 4.30 4.91 4.59
-40.73 -44.82 -52.05 -62.52 -56.15 -27.71 -30.56 -35.97 -25.56 -29.54 -36.17 -44.74
-8.69 -5.48 -1.14 3.34 2.84 2.70 2.22 2.93 3.44 0.55 -0.89 -2.53

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?